AII vs UPC

For growth investors, American Integrity Insurance Group, Inc.

(AII) is the stronger pick with 1. 7% revenue growth year-over-year, versus -22. 4% for Universe Pharmaceuticals Inc. (UPC). American Integrity Insurance Group, Inc. (AII) offers the better valuation at 10. 0x trailing P/E (6. 8x forward), making it the more compelling value choice. Analysts rate American Integrity Insurance Group, Inc. (AII) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, American Integrity Insurance Group, Inc.

(AII) delivered a total return of +20. 3%, compared to -100. 0% for Universe Pharmaceuticals Inc. (UPC). Over 10 years, the gap is even starker: AII returned +20. 3% versus UPC's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), American Integrity Insurance Group, Inc.

(AII) is the lower-risk stock at 0. 49β versus Universe Pharmaceuticals Inc. 's 1. 26β — meaning UPC is approximately 159% more volatile than AII relative to the S&P 500. On balance sheet safety, American Integrity Insurance Group, Inc. (AII) carries a lower debt/equity ratio of 2% versus 16% for Universe Pharmaceuticals Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), American Integrity Insurance Group, Inc.

(AII) is pulling ahead at 1. 7% versus -22. 4% for Universe Pharmaceuticals Inc. (UPC). On earnings-per-share growth, the picture is similar: Universe Pharmaceuticals Inc. grew EPS 26. 5% year-over-year, compared to 5. 4% for American Integrity Insurance Group, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

American Integrity Insurance Group, Inc.

(AII) is the more profitable company, earning 19. 4% net margin versus -20. 6% for Universe Pharmaceuticals Inc. — meaning it keeps 19. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AII leads at 25. 0% versus -16. 3% for UPC. At the gross margin level — before operating expenses — AII leads at 40. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, AII (3.

2% yield) pays a dividend. UPC does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, American Integrity Insurance Group, Inc.

(AII) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 49), 3. 2% yield). Both have compounded well over 10 years (AII: +20. 3%, UPC: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (AII (Financial Services) and UPC (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: AII is a small-cap deep-value stock; UPC is a small-cap quality compounder stock. AII pays a dividend while UPC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.